Back to today’s briefing

Story perspectives

Silicon Valley's Genetic Testing Sparks Ethical Debate

6/2/2025

43 7

Summary

Story summary

Silicon Valley startups like Orchid and Nucleus are revolutionizing embryo selection with polygenic testing, promising to boost health and intelligence in future generations. However, critics warn of unproven science and misleading risk scores. As affluent parents flock to these services, ethical dilemmas surrounding genetic selection and misinformation loom large, sparking a heated debate about the future of humanity.

1 of 1

Story summary

Silicon Valley startups like Orchid and Nucleus are revolutionizing embryo selection with polygenic testing, promising to boost health and intelligence in future generations. However, critics warn of unproven science and misleading risk scores. As affluent parents flock to these services, ethical dilemmas surrounding genetic selection and misinformation loom large, sparking a heated debate about the future of humanity.